Literature DB >> 3237308

Effects of muscimol and baclofen on levels of monoamines and their metabolites in the El mouse brain.

H Kabuto1, I Yokoi, A Mori.   

Abstract

We compared the changes in monoamines and their metabolites in the El mouse brain induced by GABA-A and GABA-B receptor agonists. Muscimol was used as a GABA-A receptor agonist, and baclofen as a GABA-B receptor agonist. Muscimol (3 mg/kg) significantly increased the DOPAC level in all parts of the mouse brain and the HVA level in the cortex, striatum, and midbrain. No significant change was observed in the dopamine (DA) level. These findings suggest that muscimol may accelerate both the synthesis and catabolism of DA. Baclofen (20 mg/kg) increased the DA level in the hippocampus and midbrain, and the DOPAC level in the hippocampus. Muscimol increased 5-HIAA levels and decreased 5-HT levels. This result suggests that 5-HT metabolism is accelerated by muscimol. No change in 5-HT or 5-HIAA levels was induced by baclofen. The GABA-A receptor system seems to have a potent effect not only on DA neurons, but on 5-HT neurons. However, the GABA-B receptor system appears to have almost no effect on 5-HT neurons, though it appears to have some effect on DA neurons.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3237308     DOI: 10.1007/bf00971633

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  30 in total

1.  Evidence for an inhibitory gabergic control of the meso-limbic dopamine neurons: possibility of improving treatment of schizophrenia by combined treatment with neuroleptics and gabergic drugs.

Authors:  K Fuxe; T Hökfelt; A Ljungdahl; L Agnati; O Johansson; M Perez de la Mora
Journal:  Med Biol       Date:  1975-06

2.  The effect of intracerebroventricularly administered GABA on brain monoamine metabolism.

Authors:  B Biswas; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-08       Impact factor: 3.000

3.  Dopaminergic axons directly make synapses with GABAergic neurons in the rat neostriatum.

Authors:  Y Kubota; S Inagaki; S Kito; J Y Wu
Journal:  Brain Res       Date:  1987-03-17       Impact factor: 3.252

4.  GABAB-receptor mediated inhibition of potassium-evoked release of endogenous 5-hydroxytryptamine from mouse frontal cortex.

Authors:  J A Gray; A R Green
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

5.  Metabolic studies on ep mouse, a special strain with convulsive predisposition.

Authors:  M Kurokawa; H Naruse; M Kato
Journal:  Prog Brain Res       Date:  1966       Impact factor: 2.453

6.  Parallel changes in the sensitivity of gamma-aminobutyric acid and noradrenergic receptors following chronic administration of antidepressant and GABAergic drugs. A possible role in affective disorders.

Authors:  P D Suzdak; G Gianutsos
Journal:  Neuropharmacology       Date:  1985-03       Impact factor: 5.250

7.  Potent depressant action of baclofen on hippocampal epileptiform activity in vitro: possible use in the treatment of epilepsy.

Authors:  N Ogata; T Matsuo; M Inoue
Journal:  Brain Res       Date:  1986-07-09       Impact factor: 3.252

8.  Experimental febrile convulsions in epileptic chickens: the anticonvulsant effect of elevated gamma-aminobutyric acid concentrations.

Authors:  D D Johnson; R Wilcox; J M Tuchek; R D Crawford
Journal:  Epilepsia       Date:  1985 Sep-Oct       Impact factor: 5.864

9.  gamma-Aminobutyric acid (GABA) causes consistent depolarization of neurons in the guinea pig supraoptic nucleus due to an absence of GABAB recognition sites.

Authors:  N Ogata
Journal:  Brain Res       Date:  1987-02-17       Impact factor: 3.252

10.  GABAB receptor-mediated inhibition of serotonin release in the rat brain.

Authors:  E Schlicker; K Classen; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

View more
  4 in total

1.  Akitane Mori, the artistic neurochemist.

Authors:  Jiankang Liu; Midori Hiramatsu
Journal:  Neurochem Res       Date:  2008-10-21       Impact factor: 3.996

2.  Effect of 2-guanidinoethanol on levels of monoamines and their metabolites in the rat brain.

Authors:  I Yokoi; T Itoh; K Yufu; K Akiyama; M Satoh; S Murakami; H Kabuto; A Mori
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

3.  Influence of intraventricular application of baclofen on arterial blood pressure and neurotransmitter concentrations in the hypothalamic paraventricular nucleus of rats.

Authors:  David Czell; Turgay Efe; Matthias Preuss; Markus D Schofer; Ralf Becker
Journal:  Neurochem Res       Date:  2011-10-09       Impact factor: 3.996

4.  The effects of sho-saiko-to-go-keishi-ka-shakuyaku-to (TJ-960) on ischemia-induced changes of brain acetylcholine and monoamine levels in gerbils.

Authors:  K Haba; N Ogawa; A Mori
Journal:  Neurochem Res       Date:  1990-05       Impact factor: 3.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.